News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
150,688 Results
Type
Article (10463)
Company Profile (49)
Press Release (140176)
Section
Business (38713)
Career Advice (247)
Deals (6257)
Drug Delivery (26)
Drug Development (17903)
Employer Resources (33)
FDA (3633)
Job Trends (3338)
News (66600)
Policy (6509)
Tag
Academia (881)
Alliances (13799)
Alzheimer's disease (503)
Approvals (3617)
Artificial intelligence (140)
Bankruptcy (40)
Best Places to Work (2899)
Biotechnology (36)
Breast cancer (54)
Cancer (375)
Career advice (216)
Cell therapy (80)
Clinical research (13734)
Collaboration (210)
COVID-19 (823)
Cystic fibrosis (50)
Data (339)
Diabetes (51)
Diagnostics (2140)
Drug discovery (31)
Earnings (11874)
Employer resources (28)
Events (18875)
Executive appointments (75)
FDA (3810)
Funding (139)
Gene editing (27)
Gene therapy (57)
GLP-1 (165)
Government (1317)
Healthcare (5419)
Infectious disease (849)
Inflammatory bowel disease (44)
Interviews (43)
IPO (3067)
Job creations (560)
Job search strategy (182)
Layoffs (79)
Legal (914)
Lung cancer (55)
Manufacturing (60)
Medical device (3447)
Medtech (3450)
Mergers & acquisitions (3250)
Metabolic disorders (124)
Neuroscience (580)
NextGen Class of 2024 (1511)
Non-profit (1642)
Northern California (426)
Obesity (70)
Opinion (71)
Parkinson's disease (33)
Patents (30)
People (10110)
Phase I (4507)
Phase II (6293)
Phase III (4463)
Pipeline (114)
Policy (29)
Postmarket research (464)
Preclinical (1875)
Radiopharmaceuticals (103)
Rare diseases (92)
Real estate (1087)
Regulatory (4636)
Research institute (863)
Southern California (274)
Startups (924)
United States (3628)
Vaccines (138)
Weight loss (42)
Date
Today (76)
Last 7 days (319)
Last 30 days (1108)
Last 365 days (11879)
2024 (10409)
2023 (12222)
2022 (17212)
2021 (17421)
2020 (15726)
2019 (11815)
2018 (8284)
2017 (6954)
2016 (6673)
2015 (7255)
2014 (4952)
2013 (4027)
2012 (4130)
2011 (4137)
2010 (3331)
Location
Africa (275)
Arizona (33)
Asia (11332)
Australia (1876)
California (829)
Canada (374)
China (96)
Colorado (40)
Connecticut (53)
Europe (26750)
Florida (136)
Illinois (79)
Indiana (56)
Japan (32)
Maine (29)
Maryland (155)
Massachusetts (747)
Minnesota (71)
New Hampshire (31)
New Jersey (197)
New York (290)
North Carolina (162)
Northern California (426)
Ohio (38)
Pennsylvania (215)
South America (273)
Southern California (274)
Texas (158)
Washington State (172)
150,688 Results for "atomic ai".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Investing in AI: Benefits, Regulatory Challenges
In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital discuss the opportunities, regulatory challenges and uncertainty surrounding AI.
November 7, 2024
·
1 min read
·
Lori Ellis
Drug Development
How AI Could Ease Tension in Clinical Trials
In the third episode of our mini series on artificial intelligence, Lori and guests continue their exploratory discussion on AI and the opportunity in patient lives.
October 10, 2024
·
1 min read
·
Lori Ellis
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
·
1 min read
·
BioSpace Insights
Biotech Bay
Atomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development
Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced that the Company has created the first large language model (LLM) leveraging chemical mapping data.
December 15, 2023
·
4 min read
Drug Development
AI Return on Investment: Just Because We Can, Should We?
In this episode, Lori and guests continue their exploratory discussion on AI and focus on the challenges of globalization and return on investment.
September 26, 2024
·
1 min read
·
Lori Ellis
Business
Atomic AI Adds Bristol Myers Squibb Veteran Dr. Manjunath Ramarao as Chief Scientific Officer
Former BMS, Pfizer leader to help AI-driven company accelerate its development of novel medicines discovered via its proprietary RNA foundation model Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced the addition of Manjunath “Manju” Ramarao, Ph.D., as Chief Scientific Officer.
October 12, 2023
·
3 min read
Venture capital
ARCH Fuels Up With $3B to Support Next Class of AI Biotechs
ARCH Venture Partners is the latest venture capital firm to raise a multi-billion-dollar fund. The cash will be used to support new startups working with AI.
September 26, 2024
·
1 min read
·
Annalee Armstrong
Business
The White House, Microsoft, SaS, Foley Hoag & Astellas Offer AI Guidance to Investors. Part One: The Present
Before companies and investors look towards the future, they must first understand the opportunities and challenges AI presents to them. From the benefits included in advancing processes to cybersecurity hazards, AI innovation is a balanced scale of oppportunities and risks.
September 23, 2024
·
10 min read
·
Lori Ellis
Deals
Flagship’s AI Company Generate Inks Deal Worth up to $1B With Novartis
Flagship Pioneering–backed Generate:Biomedicines has signed its second major Big Pharma partnership, bringing in $65 million upfront to use its AI platform to discover novel protein drug candidates.
September 24, 2024
·
2 min read
·
Annalee Armstrong
Business
Bayer and Rad AI Announce Collaboration agreement
As experts from around the globe gather at the annual Society for Informatics in Medicine conference, Bayer and Rad AI are announcing a collaboration to bring Rad AI’s cutting edge AI radiology operational solutions to Calantic ™ Digital Solution customers.
June 27, 2024
·
5 min read
1 of 15,069
Next